Assay Genie is a global life reagents company with over 120,000 products including immunoassays, antibodies, proteins & activity assays for research and development scientists. Founded in 2017, Assay Genie has offices in Dublin, Ireland & London, UK. With distributors in over 70 countries, Assay Genie works with scientists all around the World and counts Pfizer, J&J, Harvard University and many more of the World’s leading companies & universities among its customers. Company Achievements & Core Technologies Since its inception in 2017, Assay Genie has gone form strength-to-strength. The company began by building a unique digital ecommerce platform to provide immunoassays to cancer and immunology research scientists. Shortly after, Assay Genie launched over 7,000 immunoassays and in 2018 added a further 50,000 antibodies to their digital catalogue. During this period, Assay Genie added distribution partners in key markets such as the USA, UK, France, Germany and Benelux, allowing them to continue their rapid growth trajectory. 2019 saw the launch of a new technology called GeniePlex multiplex immunoassays which allowed immunology research scientists to get up to 24 times the amount of data from their experiments meaning vast workflow improvements. Since then, Assay Genie have added partners in Japan, Australia, MENA and Latin America as well as China which has become one of their biggest export partners. In 2020, Assay Genie were one of the 1st global companies to respond to SARS-CoV-2 with the launch of rapid antibody tests. Seeing a major demand for raw materials, they quickly brought vaccine and testing components such as antigens and antibodies to the market. As of 2022, Assay Genie provides over 120,000 products to scientists in over 70 countries.
